Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has caused significant
mortality and morbidity worldwide. In children, the acute SARS-CoV-2 infection is often …

Objective: To review the empirical evidence regarding neuropsychiatric illness (long
coronavirus disease [COVID]) in children and adolescents post–severe acute respiratory …

Background Two sequelae of pediatric COVID-19 have been identified, the multisystem
inflammatory syndrome in children (MIS-C) and the long COVID. Long COVID is much less …

From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became
evident that children infected with the severe acute respiratory syndrome coronavirus 2 …

The global disruption of the COVID‐19 pandemic has impacted the life of every child either
directly or indirectly. This review explores the pathophysiology, immune response, clinical …

Despite the worldwide spread of SARS-CoV-2 infection (COVID-19), knowledge of the
different clinical presentations, ways of transmission, severity and prognosis in children and …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became a
pandemic in 2020 and by March 2022 had caused more than 479 million infections and 6 …

Backround Post-COVID19 complications such as pediatric inflammatory multisystem
syndrome (PIMS) and Long-COVID19 move increasingly into focus, potentially causing …

Novel COVID-19 infections caused major morbidity and mortality globally in the adult age
group. Likewise, SARS-COV-2 infections in children are highly risky in the selected patient …

The COVID-19 pandemic has predominantly affected the adult population. The disease is
less well-defined in children (≤ 18 years). This review summarises the current …